Your session is about to expire
← Back to Search
GammaPod Radiation for Early Stage Breast Cancer
Study Summary
This trial is testing a new way to give radiation therapy to people with early stage breast cancer. The hope is that this will be a more effective and less harmful treatment than current methods.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your biopsy results show no invasion of lymphatic vessels or blood vessels.My cancer is located in just one area.My cancer is not invasive ductal carcinoma.My tumor is HER2 positive.My cancer is estrogen-receptor positive.My cancer has not spread to my lymph nodes.You have breast implants.You cannot have a magnetic resonance imaging (MRI) scan because of a known reaction to the contrast dye or because of health concerns related to the contrast dye.My tumor is not driven by estrogen.My breast cancer is non-invasive and contained within the milk ducts.I am a good candidate for surgery that aims to save most of my breast.I am currently on hormonal therapy.I am older than 45 years.I have had breast cancer in the same breast before.You are pregnant or breastfeeding because the effects of the treatment on a developing baby or breastfeeding infant are not known.I am a woman diagnosed with invasive ductal carcinoma.I have had an MRI to check my cancer and any new spots were tested and are not cancer.I have had radiation therapy to the breast with cancer.You must weigh less than 150 kg (330 lb) because that's the maximum weight the imaging loader can handle.I cannot comfortably lie on my stomach due to a physical disability.My cancer is present in multiple locations within the same organ.I am male.I cannot use the breast cup properly due to a poor fit.My tumor does not affect the skin or chest wall.The tumor must be able to be seen on a CT scan.My tumor is very close to the skin or chest wall.My tumor is larger than 3 cm.My weight is over 330 pounds.The biopsy shows invasion of lymphatic vessels or blood vessels.You can't use the breast cup because your breasts are too big or have other physical reasons.I am scheduled for a mastectomy.My cancer is not HER2 positive.Your mammogram shows widespread calcium deposits.My largest tumor is smaller than 3 cm, as confirmed by ultrasound or MRI before biopsy.I can lie on my stomach for treatment.
- Group 1: Dose Level 1: 21 Gy
- Group 2: Dose Level 3: 27 Gy
- Group 3: Dose Level 2: 24 Gy
- Group 4: Dose Level 4: 30 Gy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the sample size of this research endeavor?
"Affirmative, the information posted on clinicaltrials.gov affirms that this research project is actively seeking participants. The trial was originally posted on September 15th 2021 and has most recently been revised on November 8th 2021. This investigation requires 50 volunteers to be recruited from 4 different medical centres."
To what extent has this trial been disseminated to medical institutions?
"Participants can choose from 4 distinct clinical sites, such as Upper Chesapeake Health in Bel Air and UMMC in Baltimore. Additionally, Central Maryland Oncology Center located in Columbia is available for enrollment. The other locations will be listed during the application process."
Is there still availability to join this clinical exploration?
"Clinicaltrials.gov affirms that recruitment for this medical research is currently ongoing, with the experiment originally posted on September 15th 2021 and recently updated on November 8th 2021."
Share this study with friends
Copy Link
Messenger